Ranking Alexa Global: # 3,807,081
Server:Apache/2.4.33 (Unix)...
X-Powered-By:W3 Total Cache/0.9.7
The main IP address: 46.37.175.85,Your server United Kingdom,London ISP:UKfastnet Ltd TLD:com CountryCode:GB
The description :advanced medical solutions develops and manufactures advanced wound care dressing technologies for management of chronic and acute wounds....
This report updates in 13-Jun-2018
Created Date: | 1998-11-17 |
Changed Date: | 2016-11-10 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host admedsol.com. Currently, hosted in United Kingdom and its service provider is UKfastnet Ltd .
Latitude: | 51.508529663086 |
Longitude: | -0.12574000656605 |
Country: | United Kingdom (GB) |
City: | London |
Region: | England |
ISP: | UKfastnet Ltd |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.33 (Unix) OpenSSL/1.0.1e-fips mod_bwlimited/1.4 containing the details of what the browser wants and will accept back from the web server.
Content-Type: | text/html; charset=UTF-8 |
Content-Length: | 11383 |
X-Powered-By: | W3 Total Cache/0.9.7 |
Set-Cookie: | PHPSESSID=56ac945290913f9a74d61e25fd6db635; path=/ |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Vary: | Accept-Encoding,User-Agent |
Server: | Apache/2.4.33 (Unix) OpenSSL/1.0.1e-fips mod_bwlimited/1.4 |
Connection: | close |
Link: | |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Wed, 13 Jun 2018 12:30:37 GMT |
Referrer-Policy: | |
Content-Encoding: | gzip |
X-Pingback: |
soa: | ns1.mydyndns.org. zone-admin.dyndns.com. 2014060321 10800 1800 604800 1800 |
ns: | ns2142.dns.dyn.com. ns3173.dns.dyn.com. ns4146.dns.dyn.com. ns1132.dns.dyn.com. |
ipv4: | IP:46.37.175.85 ASN:34934 OWNER:UKFAST, GB Country:GB |
mx: | MX preference = 10, mail exchanger = mailgate.admedsol.com. |
you are using an outdated browser. please upgrade your browser to improve your experience. x news home about us company quality and regulatory innovation careers job listings corporate social responsibility modern slavery act gender pay report our technologies alginates collagen cyanoacrylates foam hydrocolloid hydrogels oxidised cellulose sutures our divisions branded liquiband® activheal ® resorba® partners request information oem foams hydrogels hydrocolloids alginates film request information downloads investor relations at a glance our business our vision and strategy our business model corporate governance corporate governance board of directors board committees audit committee nomination committee remuneration committee directors’ responsibilities key performance indicators senior management shareholder information aim rule 26 information warning to shareholders shareholder analysis financial calendar company documents advisors analysts share price information shareholder price data share price calculator share terms glossary regulatory news (rns) financial reports annual / interim reports results & presentations latest financial highlights faqs rns alert service contact our locations make an enquiry home about us company quality and regulatory innovation careers job listings corporate social responsibility modern slavery act gender pay report our technologies alginates collagen cyanoacrylates foam hydrocolloid hydrogels oxidised cellulose sutures our divisions branded liquiband® activheal ® resorba® partners request information oem foams hydrogels hydrocolloids alginates film request information downloads investor relations at a glance our business our vision and strategy our business model corporate governance corporate governance board of directors board committees audit committee nomination committee remuneration committee directors’ responsibilities key performance indicators senior management shareholder information aim rule 26 information warning to shareholders shareholder analysis financial calendar company documents advisors analysts share price information shareholder price data share price calculator share terms glossary regulatory news (rns) financial reports annual / interim reports results & presentations latest financial highlights faqs rns alert service contact our locations make an enquiry advanced medical solutions we are a leading developer and manufacturer of innovative and technologically advanced products for the global advanced wound care, surgical and wound closure markets. clinically effective advanced wound care we offer clinicians a simple, clear and cost effective wound care range whilst ensuring the best clinical outcome for the patient. safe and secure wound closure our comprehensive range of wound closure solutions is specifically designed to meet the requirements of both the patient and clinician. minimising adverse surgical outcomes we work closely with surgeons and clinicians to develop products with enhanced performance characteristics that significantly reduce the incidence of surgical site infections. advanced medical solutions limited our winsford site has been approved for authorised economic operator (aeo) status with effect from 1st april 2018. we are a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global advanced wound care, surgical and wound closure markets, focused on value for our customers and quality outcomes for patients. we manufacture a wide range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, marketed under our own brands activheal ® , liquiband ® and resorba ® and supplied to customers under their own brand labels. we manufacture products and materials out of two sites in the u.k., one in the netherlands, two in germany and one in the czech republic. our products are sold in 70 countries via a network of multinational or regional partners and distributors, as well as via our own direct sales forces in the u.k., germany, the czech republic and russia. established in 1991, we employ over 600 employees. our divisions we operate through two business units each responsible for their respective sales, marketing and research & development (r&d;) activities. both business units focus on a different strategic route to market. branded focus on selling, marketing and innovation of all ams branded products. these are sold directly and through distributors. oem focus on distribution, marketing and innovation of products that are supplied to medical device partners under their own brands. investor relations share price regulatory news lse (uk) trade on the lse:aim (symbol: ams) 321.50p 0.94 % at 01:21pm gmt 13th june 2018 data delayed at least 15 minutes view more share information investor relations page director/pdmr shareholding director shareholding 11th june 2018 result of agm result of agm 6th june 2018 notice of agm and management change miscellaneous 6th june 2018 view all rns latest corporate news authorised economic operator (aeo) our winsford site (advanced medical solutions limited) has been approved for authorised economic operator (aeo) status with effect from 1st april... read more ams wins medilink north west partnership with the nhs award 2016 is pleased to announce they have been awarded the partnership with the nhs award at the medilink north west... read more find out more about liquiband ® find out more about activheal ® find out more about resorba ® not sure what you are looking for? why not contact us and we'll see if we can assist you further. about us company careers our brands corporate social responsibility modern slavery act gender pay report our divisions branded oem investor relations our business corporate governance shareholder information share price information financial reports contact our locations make an enquiry sitemap © 2018 | privacy policy & cookies | accessibility | disclaimer
https://www.admedsol.com/investor-relations/regulatory-news-announcements/3471807-3491/
https://www.admedsol.com/about-us/quality-and-regulatory/
https://www.admedsol.com/investor-relations/financial-reports-agm-results/results-and-presentations/
https://www.admedsol.com/our-technologies/foam/
https://www.admedsol.com/investor-relations/shareholder-information/financial-calendar/
https://www.admedsol.com/wp-content/uploads/2018/03/ams_ltd_gender_pay_report.pdf
https://www.admedsol.com/investor-relations/shareholder-information/
https://www.admedsol.com/investor-relations/latest-financial-highlights/
https://www.admedsol.com/disclaimer/
https://www.admedsol.com/our-divisions/oem/hydrogels/
https://www.admedsol.com/investor-relations/regulatory-news-announcements/3474032-3505/
https://www.admedsol.com/investor-relations/shareholder-information/company-documents/
https://www.admedsol.com/our-technologies/alginates/
https://www.admedsol.com/our-divisions/branded/request-information/
https://www.admedsol.com/our-divisions/oem/hydrocolloids/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: ADMEDSOL.COM
Registry Domain ID: 2446084_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.dyndns.com
Registrar URL: http://www.oracle.com
Updated Date: 2016-11-10T04:17:14Z
Creation Date: 1998-11-17T05:00:00Z
Registry Expiry Date: 2018-11-16T05:00:00Z
Registrar: Oracle America, Inc.
Registrar IANA ID: 1040
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1 (603) 296-1595
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1132.DNS.DYN.COM
Name Server: NS2142.DNS.DYN.COM
Name Server: NS3173.DNS.DYN.COM
Name Server: NS4146.DNS.DYN.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-01-30T09:26:25Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Oracle America, Inc.
SERVERS
SERVER com.whois-servers.net
ARGS domain =admedsol.com
PORT 43
TYPE domain
DOMAIN
NAME admedsol.com
CHANGED 2016-11-10
CREATED 1998-11-17
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS1132.DNS.DYN.COM 208.76.58.132
NS2142.DNS.DYN.COM 208.76.59.142
NS3173.DNS.DYN.COM 208.76.60.173
NS4146.DNS.DYN.COM 208.76.61.146
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .